Joint destruction biomarkers for antiIL-17A therapy of inflammatory joint disease

Details for Australian Patent Application No. 2008266745 (hide)

Owner SCHERING CORPORATION

Inventors Chao, Cheng-Chi; Chen, Shi-Juan; Bowman, Edward Paul

Agent Griffith Hack

Pub. Number AU-A-2008266745

PCT Pub. Number WO2008/156865

Priority 60/945,239 20.06.07 US

Filing date 20 June 2008

Wipo publication date 24 December 2008

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156865 Priority application(s): WO2008/156865

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266746-Sirtuin modulating imidazothiazole compounds

2008266742-Use of benzyladenine to improve emergence of seeds treated with abscisic acid